Revenue
Revenue Recognized from Contract Liability
Thermo Fisher Scientific Revenue Recognized from Contract Liability decreased by 5.1% to $1.29B in Q1 2026 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionRevenue
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2025
Last reportedQ1 2026May 1, 2026
How to read this metric
Consistent conversion of contract liabilities into revenue indicates healthy project execution and fulfillment of customer obligations.
Detailed definition
Revenue recognized during the current period that was previously recorded as a contract liability (deferred revenue) at...
Peer comparison
Common in industries with long-term contracts or subscription-based models.
Metric ID:
anet_revenue_from_contract_liabilityHistorical Data
2 periods
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $1.36B | $1.29B |
| QoQ Change | — | -5.1% |
| YoY Change | — | -5.1% |
Range$1.29B – $1.36B
Avg YoY Growth-5.1%
Median YoY Growth-5.1%
Revenue Recognized from Contract Liability at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's revenue recognized from contract liability?
- Thermo Fisher Scientific (TMO) reported revenue recognized from contract liability of $1.29B in Q1 2026.
- What does revenue recognized from contract liability mean?
- Revenue earned this period that was paid for by customers in advance.